 | • レポートコード：QAF27703 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場について種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・グルカゴン様ペプチド-1（GLP-1）刺激薬市場の概要 ・世界の主要地域別グルカゴン様ペプチド-1（GLP-1）刺激薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場規模2016-2021：種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド） ・世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場予測2012-2027：種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド） ・世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場規模2016-2021：用途別（病院、薬局、その他） ・世界のグルカゴン様ペプチド-1（GLP-1）刺激薬市場予測2012-2027：用途別（病院、薬局、その他） ・グルカゴン様ペプチド-1（GLP-1）刺激薬のアメリカ市場規模と予測2016-2021 ・グルカゴン様ペプチド-1（GLP-1）刺激薬のヨーロッパ市場規模と予測2016-2021 ・グルカゴン様ペプチド-1（GLP-1）刺激薬の中国市場規模と予測2016-2021 ・グルカゴン様ペプチド-1（GLP-1）刺激薬の日本市場規模と予測2016-2021 ・グルカゴン様ペプチド-1（GLP-1）刺激薬の東南アジア市場規模と予測2016-2021 ・グルカゴン様ペプチド-1（GLP-1）刺激薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、AstraZeneca、Eli Lilly、GSK、Sanofi、Bristol-Myers Squibb、Amylin） ・グルカゴン様ペプチド-1（GLP-1）刺激薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・グルカゴン様ペプチド-1（GLP-1）刺激薬の市場動向・機会・課題 ・調査の結論 |
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.
Market Analysis and Insights: Global Glucagon Like Peptide-1 (GLP-1) Agonists Market
The global Glucagon Like Peptide-1 (GLP-1) Agonists market was valued at US$ 8816.2 in 2020 and will reach US$ 18650 million by the end of 2027, growing at a CAGR of 13.3% during 2022-2027.
Global Glucagon Like Peptide-1 (GLP-1) Agonists Scope and Market Size
The global Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon Like Peptide-1 (GLP-1) Agonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segment by Application
Hospital
Pharmacy
Other
The Glucagon Like Peptide-1 (GLP-1) Agonists market is analysed and market size information is provided by regions (countries). Segment by Application, the Glucagon Like Peptide-1 (GLP-1) Agonists market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Scope
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016 & 2021 & 2027)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts (2016-2027)
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends (2016-2027)
2 Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Forecasts by Region
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2016-2021)
2.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2016-2021)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
2.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
2.4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
2.4.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
2.4.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2016-2027)
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Competition Landscape by Players
3.1 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Sales (2016-2021)
3.2 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Revenue (2016-2021)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2020)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Company (2016-2021)
3.5 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Type (2016-2021)
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2016-2021)
4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2021)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2022-2027)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Type (2022-2027)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2022-2027)
5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Application (2016-2021)
5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2016-2021)
5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2016-2021)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2022-2027)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Application (2022-2027)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2022-2027)
6 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
6.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
6.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
6.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
6.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
6.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
6.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
6.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
6.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2016-2021)
6.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2022-2027)
7 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
7.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
7.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
7.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
7.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
8.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
8.1.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
8.1.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
8.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
8.2.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
8.2.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
8.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)
9 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
9.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
9.1.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
9.1.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
9.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
9.2.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
9.2.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
9.3 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
10.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
10.1.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
10.1.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
10.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
10.2.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
11.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
11.1.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2016-2021)
11.1.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021)
11.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
11.2.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2016-2021)
11.2.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2022-2027)
11.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
11.3.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2016-2021)
11.3.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Glucagon Like Peptide-1 (GLP-1) Agonists Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.3.5 Eli Lilly Recent Development
12.4 GSK
12.4.1 GSK Corporation Information
12.4.2 GSK Business Overview
12.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.4.5 GSK Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.5.5 Sanofi Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Amylin
12.7.1 Amylin Corporation Information
12.7.2 Amylin Business Overview
12.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.7.5 Amylin Recent Development
…
13 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis
13.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
13.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
14.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
15 Market Dynamics
15.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
15.2 Glucagon Like Peptide-1 (GLP-1) Agonists Drivers
15.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
15.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Region (2016-2021)
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2016-2021)
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Region (2016-2021)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share Forecast by Region (2022-2027)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2016-2021)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Company (2016-2021)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2020)
Table 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites and Area Served
Table 19. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2016-2021)
Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2016-2021)
Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2016-2021)
Table 25. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2022-2027)
Table 26. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2022-2027)
Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2022-2027)
Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2016-2021)
Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2016-2021)
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Application (2016-2021)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2022-2027)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2022-2027)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2022-2027)
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Application (2022-2027)
Table 38. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 39. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 40. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 42. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 43. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 44. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 45. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 46. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 47. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 48. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 49. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 50. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 51. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 52. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 54. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 55. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 56. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 57. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 58. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 59. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 60. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 61. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 62. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 63. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 64. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 66. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 67. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 68. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 69. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 70. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 71. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 72. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 73. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 74. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 75. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 76. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 78. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 79. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 80. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 81. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 82. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 83. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 84. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 85. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 98. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Company (2016-2021)
Table 99. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2016-2021)
Table 100. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2016-2021)
Table 102. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021) & (K Units)
Table 103. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2021)
Table 104. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2022-2027) & (K Units)
Table 105. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2022-2027)
Table 106. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021) & (K Units)
Table 107. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2021)
Table 108. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2022-2027) & (K Units)
Table 109. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2022-2027)
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 114. Novo Nordisk Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 119. AstraZeneca Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 124. Eli Lilly Recent Development
Table 125. GSK Corporation Information
Table 126. GSK Description and Business Overview
Table 127. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 129. GSK Recent Development
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 134. Sanofi Recent Development
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Amylin Corporation Information
Table 141. Amylin Description and Business Overview
Table 142. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 144. Amylin Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 148. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 149. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Table 150. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Table 151. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 152. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists: 2016 & 2020
Figure 28. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2016-2021)
Figure 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2016-2021)
Figure 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 34. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 35. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 36. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 37. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 38. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 39. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 40. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 41. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 42. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 43. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 44. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure 47. Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure 48. Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界のグルカゴン様ペプチド-1受容体アゴニスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glucagon-like Peptide-1 Receptor Agonist Market The global Glucagon-like Peptide-1 Receptor Agonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- グルカゴン様ペプチド2受容体のグローバル市場調査 2019年 The global Glucagon Like Peptide 2 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glucagon Like Peptide 2 Receptor volume and value at global level, regional level and company level. From …
- 世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global GLP-1 Receptor Agonists Market The global GLP-1 Receptor Agonists market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
- グルカゴンのグローバル市場2021 Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control syst…
- 世界のペプチドマイクロアレイ市場規模・現状・予測（2021年-2027年） Peptide microarrays is the powerful technology in the field of proteomics and clinical assays that trace the binding activities, histone-modifying enzymes and function of protein linkages on a large scale. Market Analysis and Insights: Global Peptide Microarray Market The global Peptide Microarray m…